WAM
VRTX icon

WFA Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

WFA Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6
Closed -$2.09K – 256
2023
Q3 		$2.09K Buy
+6
New +$2.1K ﹤0.01% 217

Other funds holding VRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

WFA Asset Management's VRTX Position: Q4 2023 in Review

WFA Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2023, closing a stake of 6 shares — an estimated $2.09K sold.

WFA Asset Management first reported a position in VRTX in Q3 2023 and held it in 1 quarter. The position peaked at $2.09K in Q3 2023. 1,439 funds tracked by Wall St. Rank hold VRTX as of Q4 2023.

  • WFA Asset Management reported no remaining Vertex Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • WFA Asset Management sold 6 Vertex Pharmaceuticals shares in Q4 2023, an estimated $2.09K.
  • WFA Asset Management first reported a position in Vertex Pharmaceuticals in Q3 2023 and held it in 1 quarter.
  • WFA Asset Management's Vertex Pharmaceuticals position peaked at $2.09K in Q3 2023.
  • 1,439 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2023.

Based on WFA Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.